Lyme neuroborreliosis in children.
Lyme neuroborreliosis (LNB) represents the second most frequent manifestation of Lyme disease (LD) in Europe after cutaneous involvement. In the USA, LNB represents the third most frequent manifestation of LD after cutaneous involvement and arthritis. The scope of this article is, in the light of recent publications, to review the specific manifestations of LNB in children including predictive models, and to discuss diagnosis criteria, new diagnostic tools and new therapeutic options. Differences in disease patterns between the USA and Europe are also highlighted.
Tuerlinckx
David
D
Cliniques Universitaires de Mont-Godinne, Université Catholique de Louvain, Département de Pédiatrie, Yvoir, Belgium. david.tuerlinckx@uclouvain.be
Glupczynski
Youri
Y
D000907:Antibodies, Bacterial; D002648:Child; D005060:Europe / Q000453:epidemiology; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D000907:Antibodies, Bacterial